DavisSR, Castelo-BrancoC, ChedrauiP, et al.; Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric, 2012; 15(5):419–429; doi: 10.3109/13697137.2012.707385
2.
LovejoyJC, ChampagneCM, de JongeL, et al.Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond), 2008; 32(6):949–958; doi: 10.1038/ijo.2008.25
3.
O’NeillB, RaggiP. The ketogenic diet: Pros and cons. Atherosclerosis, 2020; 292:119–126.
4.
Rovira-LlopisS, Luna-MarcoC, Perea-GaleraL, et al.Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis. Rev Endocr Metab Disord, 2024; 25(2):325–337; doi: 10.1007/s11154-023-09853-x
5.
JensenMD, RyanDH, ApovianCM, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation, 2014; 129(25_suppl_2):S102–S138; doi: 10.1161/01.cir.0000437739.71477.ee Epub 2013 Nov 12. Erratum in: Circulation. 2014 Jun 24;129(25 (Suppl 2)):S139-S140.
6.
Paddon-JonesD, WestmanE, MattesRD, et al.Protein, weight management, and satiety. Am J Clin Nutr, 2008; 87(5):1558S–1561S; doi: 10.1093/ajcn/87.5.1558S
7.
KnightM, AnekweC, WashingtonK, et al.Weight regulation in menopause. Menopause, 2021; 28(8):960–965; doi: 10.1097/GME.0000000000001792
8.
WildingJPH, BatterhamRL, CalannaS, et al.; STEP 1 Study Group. Once-Weekly Semaglutide in adults with overweight or obesity. N Engl J Med, 2021; 384(11):989–1002.
9.
GudzuneKA, KushnerRF. Medications for Obesity: A Review. JAMA, 2024; 332(7):571–584; doi: 10.1001/jama.2024.10816
10.
ArdJ, FitchA, FruhS, et al.Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Adv Ther, 2021; 38(6):2821–2839; doi: 10.1007/s12325-021-01710-0
11.
GarveyWT, MechanickJI, BrettEM, et al.; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract, 2016; 22(Suppl 3):1–203.
12.
MehtaJ, KlingJM, MansonJE. Risks, benefits, and treatment modalities of menopausal hormone therapy: Current concepts. Front Endocrinol (Lausanne), 2021; 12:564781; doi: 10.3389/fendo.2021.564781
13.
ApovianCM, AronneLJ, BessesenDH, et al.; Endocrine Society. Pharmacological management of obesity: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2015; 100(2):342–362.
14.
VermaS, ButlerJ, BorlaugBA, et al.; STEP-HFpEF Trial Committees and Investigators. Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials. J Am Coll Cardiol, 2024; 84(9):773–785; doi: 10.1016/j.jacc.2024.06.001
15.
WolfeBM, KvachE, EckelRH. Treatment of obesity: Weight loss and bariatric surgery. Circ Res, 2016; 118(11):1844–1855; doi: 10.1161/CIRCRESAHA.116.307591
16.
RisiR, RossiniG, TozziR, et al.Sex difference in the safety and efficacy of bariatric procedures: A systematic review and meta-analysis. Surg Obes Relat Dis, 2022; 18(7):983–996; doi: 10.1016/j.soard.2022.03.022
